Drug intelligence / Profile preview

juhong pian

Development stage: Unknown
Lead developer: Liaoning Jindan Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Juhong Pian is a traditional Chinese medicine (TCM) formulation primarily used for respiratory conditions. Developed and manufactured by Liaoning Jindan Pharmaceutical, it is an approved product in China. The formulation typically aims to clear heat from the lungs, resolve phlegm, and alleviate coughs. It is indicated for patients presenting with cough, excessive phlegm that is difficult to expectorate, and chest congestion. As a multi-herb TCM, its therapeutic effects are derived from the synergistic actions of its constituent botanicals, such as *Exocarpium Citri Grandis*, which is recognized for its antitussive and expectorant properties. The product is standardized according to the Chinese Pharmacopoeia.

Other names: 橘红片Juhong tablets

Beyond the preview

Go deeper on juhong pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on juhong pian.

Explore the full profile